A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Nkarta, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 884,272 shares of NKTX stock, worth $2.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
884,272
Previous 912,872 3.13%
Holding current value
$2.1 Million
Previous $5.4 Million 25.93%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.52 - $8.0 $129,271 - $228,800
-28,600 Reduced 3.13%
884,272 $4 Million
Q2 2024

Aug 09, 2024

BUY
$5.27 - $10.82 $516,459 - $1.06 Million
98,000 Added 12.03%
912,872 $5.4 Million
Q1 2024

May 13, 2024

BUY
$5.59 - $15.71 $878,189 - $2.47 Million
157,100 Added 23.88%
814,872 $8.81 Million
Q4 2023

Feb 13, 2024

BUY
$1.31 - $6.6 $190,212 - $958,320
145,200 Added 28.33%
657,772 $4.34 Million
Q3 2023

Nov 14, 2023

BUY
$1.39 - $2.29 $262,115 - $431,829
188,572 Added 58.2%
512,572 $712,000
Q2 2023

Aug 11, 2023

BUY
$2.19 - $5.17 $176,733 - $417,219
80,700 Added 33.17%
324,000 $710,000
Q1 2023

May 12, 2023

BUY
$3.37 - $6.3 $32,352 - $60,480
9,600 Added 4.11%
243,300 $864,000
Q4 2022

Feb 13, 2023

BUY
$5.14 - $14.35 $80,698 - $225,295
15,700 Added 7.2%
233,700 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$12.27 - $18.39 $2.3 Million - $3.45 Million
-187,600 Reduced 46.25%
218,000 $2.87 Million
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $1.33 Million - $3.34 Million
171,600 Added 73.33%
405,600 $5 Million
Q1 2022

May 13, 2022

BUY
$8.66 - $14.99 $832,226 - $1.44 Million
96,100 Added 69.69%
234,000 $2.66 Million
Q4 2021

Feb 11, 2022

BUY
$12.79 - $26.88 $1.37 Million - $2.88 Million
107,300 Added 350.65%
137,900 $2.12 Million
Q3 2021

Nov 12, 2021

BUY
$26.67 - $38.76 $816,102 - $1.19 Million
30,600 New
30,600 $851,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $115M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.